CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
CryoLife, an implantable biological medical device and cardiovascular tissue processing company, agreed to acquire surgical product maker, Cardiogenesis Corp. for about $22 million.
cryolife
Cohera Receives Approval for Surgical Adhesive Trial
Pittsburgh-based Cohera Medical has received approval to begin clinical trials on its TissuGlu surgical adhesive in Europe.
BioGlue Used In Over Half a Million Surgeries
CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.